Black Spade and founder of dragon-i Gilbert Yeung sign MOU to join forces to revolutionise entertainment business worldwide
HONG KONG SAR - Media OutReach Newswire - 2 February 2024 - Black Spade Capital…
3 years ago
Qiai (Qichun Mugwort) Brand Initiates Global Creative Call, Inviting Discerning Creative Minds to Shape an Iconic Brand Identity
QICHUN, CHINA - Media OutReach Newswire - 2 February 2024 - Qiai (Qichun Mugwort), an…
3 years ago
Four Budget-Friendly Finds on Shopee Live To Transform Your Home this Chinese New Year
KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 02 February 2024 - As Chinese New…
3 years ago
Nidec Announces that Takisawa Consolidates Shares and Becomes a Wholly Owned Subsidiary of Nidec
KYOTO, Japan--(BUSINESS WIRE)--Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Companyâ€) announced today that Takisawa…
3 years ago
Delta-Fly Pharma Inc.: Notice of Initiation of Phase III Pivotal comparative clinical trial of DFP-14323
TOKUSHIMA, Japan--(BUSINESS WIRE)--We are excited to share our latest development status. As presented at 2022…
3 years ago
Elliptic Labs Signs Software License Contract with New Smartphone Customer
OSLO, Norway--(BUSINESS WIRE)--#AIVirtualProximitySensor--Elliptic Labs (OSE: ELABS), a global AI software company and the world leader…
3 years ago
Greater Bay Airlines launches Bangkok – Hong Kong companion fare promotion to celebrate Lunar New Year
HONG KONG SAR - Media OutReach Newswire - 2 February 2024 - Greater Bay Airlines…
3 years ago
Greater Bay Airlines launches special promotion to celebrate the first anniversary of scheduled service to Japan
HONG KONG SAR - Media OutReach Newswire - 2 February 2024 - Greater Bay Airlines…
3 years ago
Investor Group Submits Value-Enhancing Shareholder Proposals for Consideration at Samsung C&T Corporation’s 2024 Annual General Meeting
Investor Group Consists of Local and Foreign Long-Term Shareholders, Including ANDA Asset Management, City of…
3 years ago
Sirius Therapeutics Begins Phase 1 Clinical Trial of Next-Generation, Long-Acting Factor XI siRNA Anticoagulant for Treatment of Thromboembolic Disorders
SAN DIEGO & SHANGHAI--(BUSINESS WIRE)--Sirius Therapeutics, announced it has dosed the first subject in a…
3 years ago